論文

査読有り
2010年4月

Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
  • Veronika Akopian
  • Peter W. Andrews
  • Stephen Beil
  • Nissim Benvenisty
  • Jennifer Brehm
  • Megan Christie
  • Angela Ford
  • Victoria Fox
  • Paul J. Gokhale
  • Lyn Healy
  • Frida Holm
  • Outi Hovatta
  • Barbara B. Knowles
  • Tenneille E. Ludwig
  • Ronald D. G. McKay
  • Takamichi Miyazaki
  • Norio Nakatsuji
  • Steve K. W. Oh
  • Martin F. Pera
  • Janet Rossant
  • Glyn N. Stacey
  • Hirofumi Suemori
  • 全て表示

46
3-4
開始ページ
247
終了ページ
258
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s11626-010-9297-z
出版者・発行元
SPRINGER

There are many reports of defined culture systems for the propagation of human embryonic stem cells in the absence of feeder cell support, but no previous study has undertaken a multi-laboratory comparison of these diverse methodologies. In this study, five separate laboratories, each with experience in human embryonic stem cell culture, used a panel of ten embryonic stem cell lines (including WA09 as an index cell line common to all laboratories) to assess eight cell culture methods, with propagation in the presence of Knockout Serum Replacer, FGF-2, and mouse embryonic fibroblast feeder cell layers serving as a positive control. The cultures were assessed for up to ten passages for attachment, death, and differentiated morphology by phase contrast microscopy, for growth by serial cell counts, and for maintenance of stem cell surface marker expression by flow cytometry. Of the eight culture systems, only the control and those based on two commercial media, mTeSR1 and STEMPRO, supported maintenance of most cell lines for ten passages. Cultures grown in the remaining media failed before this point due to lack of attachment, cell death, or overt cell differentiation. Possible explanations for relative success of the commercial formulations in this study, and the lack of success with other formulations from academic groups compared to previously published results, include: the complex combination of growth factors present in the commercial preparations; improved development, manufacture, and quality control in the commercial products; differences in epigenetic adaptation to culture in vitro between different ES cell lines grown in different laboratories.

リンク情報
DOI
https://doi.org/10.1007/s11626-010-9297-z
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/20186512
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000276768700014&DestApp=WOS_CPL
ID情報
  • DOI : 10.1007/s11626-010-9297-z
  • ISSN : 1071-2690
  • PubMed ID : 20186512
  • Web of Science ID : WOS:000276768700014

エクスポート
BibTeX RIS